JP2003514565A5 - - Google Patents

Download PDF

Info

Publication number
JP2003514565A5
JP2003514565A5 JP2001539890A JP2001539890A JP2003514565A5 JP 2003514565 A5 JP2003514565 A5 JP 2003514565A5 JP 2001539890 A JP2001539890 A JP 2001539890A JP 2001539890 A JP2001539890 A JP 2001539890A JP 2003514565 A5 JP2003514565 A5 JP 2003514565A5
Authority
JP
Japan
Prior art keywords
cell
site
vector
vpx
vpr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001539890A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003514565A (ja
Filing date
Publication date
Priority claimed from EP99123498A external-priority patent/EP1103615A1/en
Application filed filed Critical
Publication of JP2003514565A publication Critical patent/JP2003514565A/ja
Publication of JP2003514565A5 publication Critical patent/JP2003514565A5/ja
Pending legal-status Critical Current

Links

JP2001539890A 1999-11-25 2000-11-24 非分裂細胞を不死化する能力をもつベクター及び前記ベクターで不死化された細胞 Pending JP2003514565A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99123498A EP1103615A1 (en) 1999-11-25 1999-11-25 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors
EP99123498.0 1999-11-25
PCT/EP2000/011723 WO2001038548A2 (en) 1999-11-25 2000-11-24 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors

Publications (2)

Publication Number Publication Date
JP2003514565A JP2003514565A (ja) 2003-04-22
JP2003514565A5 true JP2003514565A5 (enExample) 2008-01-24

Family

ID=8239461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001539890A Pending JP2003514565A (ja) 1999-11-25 2000-11-24 非分裂細胞を不死化する能力をもつベクター及び前記ベクターで不死化された細胞

Country Status (6)

Country Link
US (1) US20090142841A1 (enExample)
EP (2) EP1103615A1 (enExample)
JP (1) JP2003514565A (enExample)
AU (1) AU2667901A (enExample)
CA (1) CA2389667A1 (enExample)
WO (1) WO2001038548A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006304392B2 (en) 2005-10-18 2014-05-01 National Jewish Health Conditionally immortalized long-term stem cells and methods of making and using such cells
JP2010521170A (ja) 2007-03-13 2010-06-24 ナショナル ジューイッシュ ヘルス 抗体の生成方法
TW200902708A (en) 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
KR101803099B1 (ko) 2008-05-16 2017-11-30 타이가 바이오테크놀로지스, 인코포레이티드 항체 및 그 제조 방법
ES2525411T3 (es) * 2008-07-21 2014-12-22 Taiga Biotechnologies, Inc. Células anucleadas diferenciadas y método para preparar las mismas
ES2681478T3 (es) 2008-08-28 2018-09-13 Taiga Biotechnologies, Inc. Moduladores de MYC, métodos de uso de los mismos y métodos para identificar agentes que modulan MYC
JP2013511275A (ja) 2009-11-18 2013-04-04 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 組織再生を誘導する方法
JP5863338B2 (ja) * 2011-08-25 2016-02-16 株式会社東芝 プラスミド型ベクター、遺伝子プロモーター活性の検出方法、及びアッセイキット
WO2013057164A1 (en) 2011-10-18 2013-04-25 Sarl Endocells Production of a human beta cell line from an early post natal pancreas
EP2877189B1 (en) 2012-07-20 2021-01-06 Taiga Biotechnologies, Inc. Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
WO2014109696A1 (en) * 2013-01-10 2014-07-17 Alf Grandien Method for immortalization of b cells and uses thereof
US10272115B2 (en) 2013-03-11 2019-04-30 Taiga Biotechnologies, Inc. Production and use of red blood cells
US9365825B2 (en) 2013-03-11 2016-06-14 Taiga Biotechnologies, Inc. Expansion of adult stem cells in vitro
CN103468746B (zh) * 2013-09-28 2015-03-04 青岛麦迪赛斯生物科技有限公司 一种肿瘤细胞系的构建方法
US11629337B2 (en) 2016-05-11 2023-04-18 Animal Cell Therapy—Act Production of a canine beta cell line from an immature pancreas
EP4242298A2 (en) 2016-12-02 2023-09-13 Taiga Biotechnologies, Inc. Nanoparticle formulations
US10149898B2 (en) 2017-08-03 2018-12-11 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma
US20210369788A1 (en) 2017-11-08 2021-12-02 Animal Cell Therapy - Act Production of canine pancreatic islets from an immature pancreas
AU2020272664A1 (en) 2019-04-08 2021-11-04 Taiga Biotechnologies, Inc. Compositions and methods for the cry opreservation of immune cells
AU2020274117A1 (en) 2019-05-14 2021-12-02 Taiga Biotechnologies, Inc. Compositions and methods for treating T cell exhaustion
CN111154807B (zh) * 2020-01-17 2023-03-24 山东农业大学 一种分泌型的崂山奶山羊乳腺上皮细胞系的构建方法
WO2022066937A1 (en) * 2020-09-23 2022-03-31 Regents Of The University Of Minnesota Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use
JPWO2022097716A1 (enExample) * 2020-11-06 2022-05-12
KR102572595B1 (ko) * 2020-12-02 2023-08-31 충북대학교 산학협력단 불멸화 고양이줄기세포 또는 이의 엑소좀풍부배양액을 유효성분으로 포함하는 염증성 질환의 예방 또는 치료용 조성물
KR102456805B1 (ko) * 2020-12-02 2022-10-24 충북대학교 산학협력단 불멸화 개줄기세포 또는 이의 엑소좀풍부배양액을 유효성분으로 포함하는 염증성 질환의 예방 또는 치료용 조성물
CN112941033A (zh) * 2021-03-11 2021-06-11 深圳市人民医院 永生化饲养层细胞株的构建方法、永生化饲养层细胞株及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686306A (en) * 1992-05-13 1997-11-11 Board Of Regents, The University Of Texas System Methods and reagents for lengthening telomeres
US5919997A (en) * 1993-11-18 1999-07-06 Cold Spring Habor Labortary Transgenic mice having modified cell-cycle regulation
US5729597A (en) * 1995-05-16 1998-03-17 At&T Corp Service and information management system for a telecommunications network
US5629159A (en) * 1995-06-07 1997-05-13 California Institute Of Technology Immortalization and disimmortalization of cells
US6013516A (en) * 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
WO1998000537A1 (en) * 1996-07-01 1998-01-08 Universite De Sherbrooke Composition and methods for modulating the length of telomeres
CA2265522A1 (en) * 1996-09-17 1998-03-26 The Salk Institute For Biological Studies Retroviral vectors capable of transducing non-dividing cells
AU7332198A (en) * 1997-03-06 1998-09-22 Klaus Uberla Lentivirus based vector and vector system
JP2001517433A (ja) * 1997-09-24 2001-10-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 非霊長類レンチウイルスベクターおよびパッケージングシステム
WO1999035243A2 (en) * 1998-01-12 1999-07-15 Cold Spring Harbor Laboratory Extension of cellular lifespan, methods and reagents
US6365150B1 (en) * 1998-05-13 2002-04-02 Genetix Pharmaceuticals, Inc. Lentiviral packaging cells

Similar Documents

Publication Publication Date Title
JP2003514565A5 (enExample)
Korber et al. T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces
Salminen et al. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning
Courgnaud et al. Characterization of a novel simian immunodeficiency virus with a vpu gene from greater spot-nosed monkeys (Cercopithecus nictitans) provides new insights into simian/human immunodeficiency virus phylogeny
Louwagie et al. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin
Courgnaud et al. Characterization of a novel simian immunodeficiency virus from guereza colobus monkeys (Colobus guereza) in Cameroon: a new lineage in the nonhuman primate lentivirus family
DK33190D0 (da) Hiv-3 retrovirus og anvendelse heraf
ATE520783T1 (de) Lentivirale vektoren
JP2019504868A5 (enExample)
US20110150915A1 (en) Polyvalent vaccine
Takeda et al. Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model
Santra et al. Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses
Barlow et al. Characterization of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona)
Bogers et al. Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge
De Boer et al. How germinal centers evolve broadly neutralizing antibodies: the breadth of the follicular helper T cell response
Kawada et al. Long-term control of simian immunodeficiency virus replication with central memory CD4+ T-cell preservation after nonsterile protection by a cytotoxic T-lymphocyte-based vaccine
Wang et al. Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex
Johnson et al. Molecular clones of SIVsm and SIVagm: experimental infection of macaques and African green monkeys
Agwale et al. A Tat subunit vaccine confers protective immunity against the immune-modulating activity of the human immunodeficiency virus type-1 Tat protein in mice
ATE292186T1 (de) Konditionell kontrollierter, attenuierter hiv-1 impfstoff
ATE323776T1 (de) Retrovirale vektoren zur expression in embryonalen zellen
Liegeois et al. Molecular characterization of a novel simian immunodeficiency virus lineage (SIVtal) from northern talapoins (Miopithecus ogouensis)
Lockey et al. Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees
Wang et al. Synthetic biology approach for the development of conditionally replicating HIV‐1 vaccine
JP2002523426A5 (enExample)